Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The myelodysplastic syndromes: towards a functional classification

A Mijović1, G J Mufti

  • 1Department of Haematological Medicine, King's College Hospital Denmark Hill, London, UK.

Blood Reviews
|July 14, 1998
PubMed
Summary

The French-American-British classification for myelodysplastic syndromes (MDS) needs updating due to new techniques. A revised classification incorporating biological features will improve MDS understanding and treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The clinical and histopathological spectrum of neutrophilic inflammatory disease encountered in the setting of myelodysplastic syndrome.

Clinical and experimental dermatology·2021
Same author

Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sézary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation.

Bone marrow transplantation·2021
Same author

Prenatal Management of Pregnancies at Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT): Scientific Impact Paper No. 61.

BJOG : an international journal of obstetrics and gynaecology·2019
Same author

Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia.

Leukemia·2018
Same author

A single unit transfusion policy reduces red cell transfusions in general medical in-patients.

QJM : monthly journal of the Association of Physicians·2017
Same author

Use of granulocyte transfusions among haematology units in England and North Wales.

Transfusion medicine (Oxford, England)·2017

Area of Science:

  • Hematology
  • Oncology
  • Genetics

Background:

  • The French-American-British (FAB) classification has been pivotal for myelodysplastic syndromes (MDS) research and clinical trials.
  • Morphological assessments alone are insufficient given recent advancements in diagnostic technologies.

Observation:

  • Novel cytogenetic, immunological, and molecular techniques offer deeper insights into MDS heterogeneity.
  • Existing classifications do not fully encompass newly identified MDS subtypes.

Findings:

  • A comprehensive review highlights advances in understanding MDS biology and clinical presentation.
  • Proposed alterations include incorporating therapy-induced and hereditary MDS categories.
  • The revised classification emphasizes unique biological and clinical features of MDS subtypes.

Related Experiment Videos

Implications:

  • This updated classification aims to improve communication and research focus on MDS.
  • A better understanding of MDS biological features is crucial for developing effective therapeutic strategies.
  • The classification will aid in identifying and managing diverse MDS patient populations.